MEREO BIOPHARMA GROUP PLC filings

SEC filings by MEREO BIOPHARMA GROUP PLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2023-02-14BAKER BROS. ADVISORS LPMereo Biopharma Group plc69,359,35910.0%EDGAR
SC 13G/A2023-02-14Rock Springs Capital Management LPMereo Biopharma Group plc31,224,4855.3%EDGAR
SC 13G/A2023-02-14Vivo Capital IX, LLCMereo Biopharma Group plc839,4350.7%EDGAR
SC 13G/A2023-02-13SUVRETTA CAPITAL MANAGEMENT, LLCMereo Biopharma Group plc36,822,1905.9%EDGAR
SC 13D/A2022-10-28Rubric Capital Management LPMereo Biopharma Group plc83,780,60013.4%EDGAR
SC 13D/A2022-09-23Rubric Capital Management LPMereo Biopharma Group plc83,780,60013.4%EDGAR
SC 13D/A2022-08-24Rubric Capital Management LPMereo Biopharma Group plc83,780,60014.3%EDGAR
SC 13D/A2022-06-14Rubric Capital Management LPMereo Biopharma Group plc82,272,81014.1%EDGAR
SC 13D/A2022-06-09Rubric Capital Management LPMereo Biopharma Group plc76,792,62513.1%EDGAR
SC 13D2022-05-26Rubric Capital Management LPMereo Biopharma Group plc75,000,00012.8%EDGAR
SC 13G2022-02-15Rock Springs Capital Management LPMereo Biopharma Group plc5,585,6215.1%EDGAR
SC 13G/A2022-02-14Point72 Asset Management, L.P.Mereo Biopharma Group plc10,610,0009.1%EDGAR
SC 13G/A2022-02-14CITADEL ADVISORS LLCMereo Biopharma Group plc-3.6%EDGAR
SC 13G/A2022-02-14Rubric Capital Management LPMereo Biopharma Group plc74,572,23513.7%EDGAR
SC 13G/A2022-02-14BAKER BROS. ADVISORS LPMereo Biopharma Group plc64,917,60110.0%EDGAR
SC 13G/A2022-02-14Boxer Capital, LLCMereo Biopharma Group plc4,082,5763.6%EDGAR
SC 13G/A2022-02-11SUVRETTA CAPITAL MANAGEMENT, LLCMereo Biopharma Group plc45,710,3358.4%EDGAR
SC 13G/A2022-02-11ORBIMED ADVISORS LLCMereo Biopharma Group plc3,815,6763.5%EDGAR
SC 13G/A2022-02-11Vivo Capital IX, LLCMereo Biopharma Group plc2,099,5201.8%EDGAR
SC 13G2021-12-02Rubric Capital Management LPMereo Biopharma Group plc56,500,00010.4%EDGAR